Abstract
The role of estrogen during brain development is well documented. Estrogen influences cell survival and differentiation and also controls the formation and maintenance of neural networks. Knowledge of trophic estrogen action in the central nervous system (CNS) was the basis for the establishment of research programs directed toward a potential function of estrogen as a neuroprotective factor in the adult brain. Considerable evidence has accumulated over the years supporting this hypothesis. Experimental and epidemiologic studies as well as clinical trials have demonstrated that estrogen is beneficial for the course of neurodegenerative disorders such as Parkinson and Alzheimer diseases but may also protect neurons from postischemic neuronal degeneration. In this article, we aim to unravel potential physiologic responses and cell survival strategies that allow a more detailed understanding of estrogen-mediated neuroprotection in the brain. In particular, we focus on the participation of estrogen in the regulation of apoptotic processes. Furthermore, we present data on reciprocal estrogen-growth factor interactions. Both of these mechanisms were found to operate during brain development and to conciliate estrogen effects on neurons. This makes them likely candidates for taking part in conveying estrogen-dependent neuroprotection in the adult CNS.
Similar content being viewed by others
References
Beyer, C. (1999). Anat. Embryol. 199, 379–390.
Garcia-Segura, L. M., Chowen, J. A., Parduz, A., and Naftolin, F. (1994). Prog. Neurobiol. 44, 279–307.
McEwen, B. S. (1992). Horm. Res. 37, 1–10.
McEwen, B. S. and Alves, S. E. (1999). Endocr. Rev. 20, 279–307.
Sherwin, B. B. (1998). Neurology 48, 21–26.
Henderson, V. M. (1997). CNS Drugs 8, 343–351.
Bedard, P. J., Langelier, P., and Villeneuve, A. (1977). Lancet 2, 1367, 1368.
Wise, P. M., Dubal, D. B., Wilson, M. E., Rau, S. W., Böttner, M., and Rosewell, K. L. (2001). Brain Res. Rev. 37, 313–319.
Sawada, H., Ibi, M., Urushitani, M., Akaike, A., and Shimohama, S. (1998). J. Neurosci. Res. 54, 707–719.
Harms, C., Lautenschläger, M., Bergk, A., et al. (2001). J. Neurosci. 21, 2600–2609.
Alkayed, N. J., Goto, S., Sugo, N., et al. (2001). J. Neurosci. 21, 7543–7550.
Pike, C. J. (1999). J. Neurochem. 72, 1552–1563.
Meda, C., Vegeto, E., Pollio, G., et al. (2000). J. Neuroendocrinol. 12, 1051–1059.
Behl, C. and Manthey, D. (2000). J. Neurocytol. 29, 351–359.
Ivanova, T., Mendez, P., Garcia-Segura, L. M., and Beyer, C. (2002). J. Neuroendocrinol. 14, 73–79.
Beyer, C., Ivanova, T., Karolczak, M., and Küppers, E. (2002). J. Steroid Biochem. Mol. Biol. 81, 319–325.
Behl, C., Skutella, T., Lezuaich, F., et al. (1997). Mol. Pharmacol. 51, 535–541.
Küppers, E., Ivanova, T., Karolczak, M., Lazarov, N., Föhr, K., and Beyer, C. (2001). Horm. Behav. 40, 196–202.
Falkenstein, E., Tillmann, H.-C., Christ, M., Feuring, M., and Wehling, M. (2000). Pharmacol. Rev. 52, 513–555.
Benzgen, J., Mohapel, P., Ekdahl, C. T., and Lindvall, O. (2002). Prog. Brain Res. 135, 111–119.
Voiculescu, B., Nat, R., Lin, E., and Iosef, C. (2000). J. Cell. Mol. Med. 4, 282–288.
Ghoumari, A., Wehrle, R., Bernard, O., Sotelo, C., and Dusart, I. (2000). Eur. J. Neurosci. 12, 2935–2949.
Roth, K. A. and D’Sa, C. (2001). Ment. Retard. Dev. Disabil. Res. Rev. 7, 261–266.
Mattson, M. P. (2000). Nat. Rev. Mol. Cell. Biol. 1, 120–129.
Yuan, J. and Yankner, B. A. (2000). Nature 407, 802–809.
Nagata, S. (2002). Neuroscience 115, 415–424.
Pompeiano, M., Blaschke, A. J., Flavell, R. A., Sirinivasan, A., and Chun, J. (2000). J. Comp. Neurol. 423, 1–12.
Wise, P. M. (2002). Trends Endocrinol. Metab. 13, 229,230.
Behl, C. (2002). Prog. Brain. Res. 138, 135–142.
Zhang, Y., Tounekti, O., Akerman, B., Goodyer, C. G., and LeBlanc, A. (2001). J. Neurosci. 21, 229–230.
Kajta, M., Lason, W., and Kupiec, T. (2003). Neuroscience, in press.
Horvat, A., Nikezic, G., Petrovic, S., and Kanazir, D. T. (2001). Cell. Mol. Life Sci. 58, 636–644.
Kajta, M., Budziszewska, B., Marszal, M., and Lason, W. (2001). J. Physiol. (Paris) 52, 437–446.
Harms, C., Lautenschlager, M., Bergk, A., et al. (2001). J. Neurosci. 21, 2600–2609.
Stoltzner, S. E., Berchtold, N. C., Cotman, C. W., and Pike, C. J. (2001). Neuroreport 12, 2797–2800.
Garcia-Segura, L. M., Cardona-Gomez, P., Naftolin, F., and Chowen, J. A. (1998). Neuroreport 9, 593–597.
Drew, P. D. and Chavis, J. A. (2000). J. Neuroimmunol. 111, 77–85.
Cerillo, G., Rees, A., Manchanda, N., et al. (1998). J. Steroid Biochem. Mol. Biol. 67, 79–88.
Toran-Allerand, C. D. (1996). Dev. Neurosci. 18, 36–48.
Miranda, R. C., Sohrabji, F., and Toran-Allerand, C. D. (1993). Mol. Cell. Neurosci. 4, 510–525.
Sohrabji, F., Miranda, R. C., and Toran-Allerand, C. D. (1995). Proc. Natl. Acad. Sci. USA 92, 11110–11114.
Murphy, D. D., Cole, N. B., and Segal, M. (1998). J. Neurosci. 95, 11412–11417.
Dittrich, F., Feng, Y., Metzdorf, R., and Gahr, M. (1999). Proc. Natl. Acad. Sci. USA 96, 8241–8246.
Ivanova, T., Küppers, E., Engele, J., and Beyer, C. (2001). J. Neurosci. Res. 66, 221–230.
Raab, H., Beyer, C., Wozniak, A., Hutchison, J. B., Pilgrim, C., and Reisert, I. (1995). Mol. Brain. Res. 34, 333–336.
Raab, H., Karolczak, M., Reisert, I., and Beyer, C. (1999). Neurosci. Lett. 275, 21–24.
Küppers, E., Ivanova, T., Karolczak, M., and Beyer, C. (2000). J. Neurocytol. 29, 375–385.
Beyer, C. and Karolczak, M. (2000). J. Neurosci. Res. 59, 107–116.
Rasika, S., Alvarez-Buylla, A., and Nottebohm, F. (1999). Neuron 22, 53–62.
Gibbs, R. B. (1998). Brain Res. 787, 259–268.
Binder, D. K., Croll, S. D., Gall, C. M., and Scharfman, H. E. (2001). Trends Neurosci. 24, 47–63.
Beyer, C. and Raab, H. (1998). Eur. J. Neurosci. 10, 255–262.
Aliaga, E., Rage, F., Bustos, G., and Tapia-Arancibia, L. (1998). Neuroreport 9, 1959–1962.
Hentges, S. and Sarkar, D. K. (2001). Front. Neuroendocrinol. 22, 340–363.
Melcangi, R. C., Cavaretta, I., Magnaghi, V., Martini, L., and Galbiati, R. (2001). Brain Res. Rev. 37, 223–234.
Krieglstein, K., Strehlau, J., Schober, A., Sullivan, A., and Unsicker, K. (2002). J. Physiol. (Paris) 96, 25–30.
Lin, L. F., Doherty, D. H., Lile, J. D., Bektesh, S., and Collins, F. (1993). Science 260, 1130–1132.
Burazin, T. C. D. and Gundlach, A. L. (1999). Mol. Brain Res. 73, 151–171.
Lapchak, P. A., Jiao, S., Collins, F., and Miller, P. J. (1997). Brain Res. 747, 92–102.
Simerly, R. B. (1989). Mol. Brain Res. 6, 297–310.
Beyer, C., Eusterschulte, B., Pilgrim, C., and Reisert, I. (1992). Cell Tissue Res. 270, 547–552.
Beyer, C., Pilgrim, C., and Reisert, I. (1991). J. Neurosci. 11, 1325–1333.
Ivanova, T., Karolczak, M., and Beyer, C. (2002). Endocrinology 143, 3175–3178.
Beyer, C., Wozniak, A., and Hutchison, J. B. (1993). Neuroendocrinology 58, 673–681.
Layman, L. C. (1995). Curr. Opin. Obstet. Gynecol. 7, 328–339.
Garcia-Segura, L. M., Cardona-Gomez, G. P., Chowen, A. J., and Azcoitia, I. (2000). J. Neurocytol. 29, 425–437.
Cardona-Gomez, G. P., Mendez, P., DonCarlos, L. L., Azcoitia, I., and Garcia-Segura, L. M. (2001). Brain Res. Rev. 37, 320–334.
Cardona-Gomez, G. P., Chowen, A. J., and Garcia-Segura, L. M. (2000). J. Neurobiol. 43, 269–281.
Azcoitia, I., Fernandez-Galaz, C., Sierra, C., and Garcia-Segura, L. M. (1999). J. Neurocytol. 28, 699–710.
Azcoitia, I., Sierra, A., and Garcia-Segura, L. M. (1999). Neurosci. Res. 58, 815–822.
Cheng, C. M., Cohen, M., Wang, J., and Bondy, C. A. (2001). FASEB J. 15, 907–915.
Dubal, D. B., Shughrue, P. J., Wilson, M. E., Merchenthaler, I., and Wise, P. M. (1999). J. Neurosci. 19, 6385–6393.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kajta, M., Beyer, C. Cellular strategies of estrogen-mediated neuroprotection during brain development. Endocr 21, 3–9 (2003). https://doi.org/10.1385/ENDO:21:1:3
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/ENDO:21:1:3